Rivaroxaban(Xarelto)®: Gids voor de apotheker
(2013) Farmaceutisch Tijdschrift voor Belgie — n° 1, p. 28-36 (2013)
Files
2013_Douxfils_Farm_Tijdschrift_Belg.pdf
Open Access - Adobe PDF
- 298.25 KB
Details
- Authors
- Abstract
- Rivaroxaban is one of the new oral anticoagulants (NOACs) (recommended as reference treatments when a long-term anticoagulation is needed). It has many potential advantages in comparison with Vitamin K Antagonists (VKA). It has a predictable anticoagulant effect and does not theoretically require biological monitoring. It is also characterized by less food and drug interactions. However, due to major risks associated with over- and under-dosage, its optimal use in patients should be carefully followed by health care professionals. The aim of this article is to provide recommendations for pharmacists on the practical use of Xarelto® in its different approved indications. This document is adapted from the practical user guide of rivaroxaban which was developed by an independent group of Belgian experts in the field of thrombosis and haemostasis.
- Affiliations
Citations
Douxfils, J., Michel, S., Beauloye, C., Goethals, M., Hainaut, P., Heidbuchel, H., Hermans, C., Ickx, B., Jochmans, K., Motte, S., Mullier, F., Peeters, A., Scavée, C., Sinnaeve, P., Sprynger, M., Thijs, V., Vandenbroeck, C., Vandermeulen, E., Verhamme, P., & Dogné, J.-M. (2013). Rivaroxaban(Xarelto)®: Gids voor de apotheker. Farmaceutisch Tijdschrift voor Belgie, 1, 28-36. https://hdl.handle.net/2078.5/187449 (Original work published 2013)